Raising Patient Cost Share for Specialty Medications

Debbie Stern, RPh, president of Rxperts, explains why a high entry cost for a specialty drug may dissuade a patient from filling and staying adherent to his or her prescription.

Debbie Stern, RPh, president of Rxperts, explains why a high entry cost for a specialty drug may dissuade a patient from filling and staying adherent to his or her prescription. Video from the 2013 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.

For more videos from this conference, vist our Multimedia page.